Evidence map›Paper›PMID 29038713›Full record

ArticleElectronic physician2017

Coexistence of lupus nephritis and sickle cell trait, an electron microscopic assessment of renal glomerular damage: Case report of a rare association.

Yahya Elficki, Atif Rawas, Asseil Ali Bossei, Areej Bdawod, Reem Zabani, Bayan Shams

Open access · goldAbstract readCase Reports
In one paragraph

Article in Electronic physician, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yahya ElfickiConsultant of Internal Medicine, FRCP-UK, King Abdulaziz Hospital, Jeddah, Kingdom of Saudi Arabia.
Atif RawasResearch Assistant and Coordinator, MD, King Abdulaziz Hospital, Jeddah, Kingdom of Saudi Arabia.
Asseil Ali BosseiResearch Assistant and Coordinator, MBBS student, Ibn Sina National College for Medical Science, Jeddah, Kingdom of Saudi Arabia.
Areej BdawodResearch Assistant and Coordinator, MBBS student, Ibn Sina National College for Medical Science, Jeddah, Kingdom of Saudi Arabia.
Reem ZabaniResearch Assistant and Coordinator, MBBS student, Ibn Sina National College for Medical Science, Jeddah, Kingdom of Saudi Arabia.
Bayan ShamsResearch Assistant and Coordinator, MBBS student, Ibn Sina National College for Medical Science, Jeddah, Kingdom of Saudi Arabia.
Ibn Sina National College for Medical Studies · SAKing Abdulaziz Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of similarities of the musculoskeletal, central nervous system, and renal manifestations in both diseases, diagnosing systemic lupus erythematosus (SLE) in sickle cell disease (SCD) patients can be difficult to establish. Although Sickle Cell Trait (SCT) is still considered a benign form of SCD, its impact on kidney injury and other renal manifestations is well recognized in the literature. In this case report, we look at the challenges that develop when diagnosing patients with a concurrence of both diseases and the importance of early recognition and treatment of lupus nephritis in SCT patients. We present a case of a male patient with sickle-cell trait who was admitted to our hospital complaining of low grade fever and pancytopenia for investigations proven to be SLE. A renal biopsy on electron microscopy assessment with different staining modalities as well as immune fluorescence revealed mixed pathological changes. We emphasize the importance in considering the presence of a coexisting autoimmune disease in a patient with sickle hemoglobinopathies even in the milder forms like SCT which may display an atypical and/or multisystem presentation. Also, the impact of the two conditions on the renal pathological changes should be expected to be more damaging even at early onset of SLE flare, and hence, an urge to start with more intensified immunosuppressive medications.

Indexed as

Aplastic anemiaFebrile neutropeniaLupus nephritisSickle cell traitSystemic lupus erythematosus

Identifiers

PMID29038713
PMCPMC5633229
OpenAlexW2759507330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.